Literature DB >> 17712538

[Nutrition of critically ill patients in intensive care].

K G Kreymann1, G de Heer, T Felbinger, S Kluge, A Nierhaus, U Suchner, R F Meier.   

Abstract

A concept for combined enteral and parenteral nutrition for critically ill patients is described in which endogenous substrate production during the acute phase of illness is taken into consideration and hyperalimentation is avoided. The nutritional goal is defined by multiplication of the base rate, i.e. body weight (BW) in kg as delivery rate in ml/h (wedge 24 kcal/kg BW/24 h), with a target factor, which varies between 0.2 and 1.8. An equivalent composition of enteral and parenteral nutrition allows a transition between both forms without problems. Simultaneously, immunologic aspects of nutrition are considered as well and both forms of nutrition are complemented by immune-modulating substrates such as glutamine and antioxidants.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17712538     DOI: 10.1007/s00108-007-1926-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  31 in total

Review 1.  Muscle protein metabolism during sepsis.

Authors:  P O Hasselgren
Journal:  Biochem Soc Trans       Date:  1995-11       Impact factor: 5.407

2.  A new model for studying nutrition in peritonitis. The adverse effect of overfeeding.

Authors:  J W Alexander; S J Gonce; P W Miskell; M D Peck; H Sax
Journal:  Ann Surg       Date:  1989-03       Impact factor: 12.969

3.  Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients.

Authors:  Helmut Grimm; Norbert Mertes; Christiane Goeters; Ewald Schlotzer; Konstantin Mayer; Friedrich Grimminger; Peter Fürst
Journal:  Eur J Nutr       Date:  2005-07-22       Impact factor: 5.614

Review 4.  Alterations in carbohydrate metabolism during stress: a review of the literature.

Authors:  B A Mizock
Journal:  Am J Med       Date:  1995-01       Impact factor: 4.965

Review 5.  Advances in intravenous lipid emulsions.

Authors:  Y A Carpentier; I E Dupont
Journal:  World J Surg       Date:  2000-12       Impact factor: 3.352

6.  Enteral compared with parenteral nutrition: a meta-analysis.

Authors:  C L Braunschweig; P Levy; P M Sheean; X Wang
Journal:  Am J Clin Nutr       Date:  2001-10       Impact factor: 7.045

7.  ESPEN Guidelines on Enteral Nutrition: Intensive care.

Authors:  K G Kreymann; M M Berger; N E P Deutz; M Hiesmayr; P Jolliet; G Kazandjiev; G Nitenberg; G van den Berghe; J Wernerman; C Ebner; W Hartl; C Heymann; C Spies
Journal:  Clin Nutr       Date:  2006-05-11       Impact factor: 7.324

8.  Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group.

Authors:  J E Gadek; S J DeMichele; M D Karlstad; E R Pacht; M Donahoe; T E Albertson; C Van Hoozen; A K Wennberg; J L Nelson; M Noursalehi
Journal:  Crit Care Med       Date:  1999-08       Impact factor: 7.598

9.  Optimizing the dose of glutamine dipeptides and antioxidants in critically ill patients: a phase I dose-finding study.

Authors:  Daren K Heyland; Rupinder Dhaliwalm; Andrew Day; John Drover; Helene Cote; Paul Wischmeyer
Journal:  JPEN J Parenter Enteral Nutr       Date:  2007 Mar-Apr       Impact factor: 4.016

Review 10.  Cytokine control of nutrition and metabolism in critical illness.

Authors:  W W Souba
Journal:  Curr Probl Surg       Date:  1994-07       Impact factor: 1.909

View more
  3 in total

1.  [Supplemental parenteral nutrition. Friend or foe? The EPaNIC study].

Authors:  T W Felbinger; K Mayer; H P Richter
Journal:  Med Klin Intensivmed Notfmed       Date:  2011-10-26       Impact factor: 0.840

Review 2.  [Nutrition in intensive care medicine].

Authors:  M Hecker; T Felbinger; K Mayer
Journal:  Anaesthesist       Date:  2012-06       Impact factor: 1.041

3.  [Early parenteral or enteral nutrition in intensive care patients. Results of the CALORIES Trial].

Authors:  U Janssens; W Druml
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-02       Impact factor: 0.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.